🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to INTERPHEX WEEK OSAKA — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
INTERPHEX Week Osaka / Regenerative Medicine Expo Osaka (2026)
Event overview (from official sources)
Dates: Sep. 30 – Oct. 2, 2026
Time: 10:00–17:00 (JST)
Venue: INTEX Osaka, Japan
Organiser: RX Japan GK (RX Japan 合同会社)
Event positioning: INTERPHEX Week Osaka is presented as a leading pharma industry exhibition in Japan. It includes three specialised pharma/biotech-technology-focused shows under one umbrella, and it also includes the Regenerative Medicine Expo Osaka segment.
1️⃣ Who attends (BUYERS / ATTENDEES)
This show is structured around pharma technologies and regenerative medicine—so attendance is best understood as a mix of industry decision-makers, technical buyers, R&D/production stakeholders, and clinical/research-facing professionals. Based on the official descriptions, the strongest “buyer-fit” attendee groups typically come from:
- Pharmaceutical and cosmetics manufacturers (industry specialists visiting across R&D, manufacturing, and related business functions).
- Regenerative medicine companies (tissue engineering and related technology firms coming to source products, services, and partnerships).
- Researchers/doctors from universities (because the regenerative medicine segment explicitly notes researchers/doctors from universities and other institutions visit).
- Medical institutions (involved in applied research, translational work, and evaluation of enabling technologies such as reagents, culture media, and services).
- Specialist professionals in pharma manufacturing and packaging technologies, since INTERPHEX OSAKA is described as covering pharmaceutical technologies for manufacturing & packaging.
- Digital transformation stakeholders for pharma, because Pharma Digital Transformation EXPO is included as one of the specialised shows within INTERPHEX Week Osaka.
- Contract services / licensing / enabling-supply stakeholders, since the regenerative medicine expo explicitly lists contract services and licensing among the exhibit categories.
Buyer interpretation: This is not only a “brand awareness” audience. It is a technology- and partnership-led event. Buyers most likely to convert are those who have responsibility for: vendor evaluation, tech qualification, R&D tool selection, manufacturing support, quality/compliance workflows, and collaboration pipelines (including licensing/contract services).
2️⃣ Where the show is happening + attendee geographic origin
Show location: INTEX Osaka, Japan.
City: Osaka.
Country: Japan.
The official page states that for the regenerative medicine expo, visitors include researchers/doctors from universities, pharmaceutical/cosmetics manufacturers, and medical institutions “from all over Japan and Asia.” Therefore, the geographic origin profile can be described reliably as:
- Primary origin: Japan (across regions; “all over Japan” is explicitly stated).
- Secondary origin: Asia (explicitly stated as “from all over Japan and Asia”).
- International nuance: Because Asia is explicitly mentioned, the event is positioned for cross-border technology sourcing within the broader regional network. However, the official text does not specify Europe/North America presence on this Osaka page.
Best geographic targeting for buyer lists
If we are selecting visitor/buyer leads for outreach, the highest fit messaging should be tailored to: Japan-based decision-makers and Asia-region stakeholders who need regenerative medicine / pharma manufacturing / digital transformation capabilities.
3️⃣ Audience reach (Local / National / Global)
The official site explicitly characterises Osaka as part of Japan’s leading pharma ecosystem and states that regenerative medicine visitors come “from all over Japan and Asia.” From that, we can classify reach as:
- National: Yes (Japan-wide—“all over Japan”)
- Regional/international: Yes (Asia-wide—“and Asia”)
- Global: Not explicitly claimed on this Osaka page. The official text does not provide a global reach statement beyond Asia.
Practical takeaway: For outreach and lead quality, treat the audience as Japan-centric with Asia connectivity. That positioning usually increases relevance for pharma/R&D, enabling products, and contract/partnership offers.
4️⃣ Sample buyer company names (BUYERS ONLY) + websites
Below are sample buyer targets we would typically prioritise for this kind of event (pharma, cosmetics, regenerative medicine, cell/tissue engineering enabling technologies, manufacturing support, and related digital transformation). Exact booth/exhibitor status is not confirmed on this page; the goal here is buyer-fit based on the event’s described scope.
If we receive your client product website, we will narrow this list further to the best-matching buyers by mapping your offering category to the show’s specialised themes: (1) manufacturing & packaging technologies, (2) pharma R&D and drug discovery, (3) digital transformation for pharma, and (4) regenerative medicine technologies (culture media, reagents, incubators, cell research products, contract services, licensing).
5️⃣ Job profiles, industries & event type
Event type (based on the official structure)
INTERPHEX Week Osaka includes three specialised pharma technology exhibitions and is explicitly connected to: pharmaceutical manufacturing & packaging, pharma R&D & drug discovery, digital transformation for pharma, and regenerative medicine & tissue engineering.
Best job profiles to target
For buyer-oriented outreach, we should prioritise roles that control or influence vendor selection, qualification, and partnerships. The best-match job titles typically fall into these responsibility clusters:
-
R&D leadership (Regenerative Medicine / Cell/Tissue Engineering)
- Head/Director of Regenerative Medicine R&D
- Cell Therapy / Tissue Engineering Program Lead
- Principal Investigator / Lab Director (university or institute leadership)
-
Manufacturing & Packaging / Pharma Operations
- Director, Pharmaceutical Manufacturing Technology
- Director/Manager, Packaging & Manufacturing Support
- Process Development / CMC (Chemistry, Manufacturing & Controls) Manager
-
Drug discovery & pharma R&D operations
- Head of Drug Discovery Technology
- R&D Operations Manager
- Lab Procurement / Research Procurement Lead
-
Digital transformation for pharma
- Head of Digital Transformation (Pharma)
- IT/OT Strategy Lead for Pharma Manufacturing
- Quality & Compliance Digital Solutions Manager
-
Vendor qualification, quality, and compliance-facing roles
- Quality Assurance Manager (QA)
- Regulatory Affairs Manager (where applicable to technology adoption)
- Supplier Qualification / Vendor Management Lead
-
Commercial & partnership roles relevant to contract services / licensing
- Business Development Manager (BD)
- Licensing & Partnerships Manager
- Strategic Alliances Lead
Best-fit industries (from your provided industry list)
To align with the industry categories you use, the strongest matches for this event are:
| Priority | Industry (from your list) | Why it fits this event |
|---|---|---|
| 1 | Pharmaceuticals | Core expo positioning includes pharma technologies and R&D/drug discovery. |
| 2 | Medical Devices | Regenerative medicine and tissue engineering often overlap with lab tools and device-adjacent enabling systems. |
| 3 | Hospital & Health Care | Medical institutions explicitly visit; applied research and clinical-side stakeholders are likely. |
| 4 | Biotechnology | Regenerative medicine and tissue engineering companies commonly sit in biotech workflows. |
| 5 | Chemicals | Culture media, reagents, and lab chemicals are core regenerative medicine exhibit categories. |
| 6 | Medical Practice | Where medical institutions use regenerative medicine technologies and research equipment. |
| 7 | Research | Universities and institutes are described as visiting for regenerative medicine technologies. |
| 8 | Information Technology & Services | Pharma Digital Transformation EXPO suggests solutions vendors and internal digital transformation owners. |
6️⃣ Estimated attendance (expected total footfall)
The official page excerpt we have does not state the Osaka show’s expected total attendance/footfall numbers directly. It also notes that some numbers (including visitors) on the website are “forecasts” and may differ from the actual show.
Reliable status based on the provided official text: attendee/footfall figure is not disclosed here.
7️⃣ Key focus areas & buyer engagement
This event is designed around innovation and technology sourcing across pharma and regenerative medicine. The official descriptions highlight the following focus areas:
Core focus areas
- Pharmaceutical manufacturing & packaging technologies (INTERPHEX OSAKA).
- Pharma R&D and drug discovery tools/solutions (PharmaLab Expo OSAKA).
- Digital transformation technologies and services for pharma (Pharma Digital Transformation EXPO).
- Regenerative medicine and tissue engineering technologies.
- Regenerative medicine exhibit categories including: culture media, reagents, incubators, cell research related products, contract services, and licensing.
Buyer engagement patterns we recommend
- Problem-led qualification: outreach that starts with the buyer’s workflow (cell culture, reagent selection, facility capability, vendor qualification, licensing partnership structure).
- Evidence & qualification readiness: regenerative medicine stakeholders typically need proof of performance, reproducibility, documentation, and suitability for research/manufacturing contexts.
- Cross-functional messaging: for digital transformation, pair technical value with compliance/quality and operational performance.
- Partnership and contracting angle: since contract services and licensing are listed, offer clear collaboration models (pilot programs, qualification timelines, IP/licensing structures where relevant).
8️⃣ Client-product fit note (required question + next-step process)
We can only identify the best buyers for attendee/leads selection if we review your client requirements. Please share your client product website URL (and ideally a 2–3 line description of what your client sells and who the buyer is today).
Once we receive it, we will:
- Map your product category to the event’s four described lanes (manufacturing & packaging, pharma R&D/drug discovery, pharma digital transformation, regenerative medicine/tissue engineering).
- Filter buyers toward the most relevant buyer functions (R&D, manufacturing, procurement/vendor qualification, digital transformation, and partnerships/licensing).
- Produce a prioritised buyer list with best-fit job titles and the most relevant outreach angle for each buyer segment.
Important note: We do not present lead generation as a generic “catch-all” attendee list. We position it as targeted buyer-fit research for your client’s use case.
9️⃣ Final recommendation (fit rating + who should buy)
Is INTERPHEX Week Osaka / Regenerative Medicine Expo Osaka a strong fit? Yes—particularly for clients offering: regenerative medicine enabling technologies (culture media, reagents, incubators, cell research products), contract services, licensing support, pharma manufacturing/packaging technologies, pharma R&D tools for discovery, and pharma digital transformation solutions.
Best client match profiles:
- Regenerative medicine suppliers (cell culture and lab enablement)
- Contract research / contract services / licensing-oriented partners
- Pharma manufacturing and quality-adjacent technology vendors
- Digital transformation solution providers focused on pharma workflows
- Equipment and instrumentation companies that support research and/or manufacturing readiness
Key reason: The official text clearly indicates the presence of researchers/doctors, universities, pharmaceutical/cosmetics manufacturers, and medical institutions “from all over Japan and Asia.” That buyer mix is ideal for both technical evaluation and partnership conversations.
Sample buyer list table (15–20 buyers)
The table below includes Priority, Company, Website, Best Title to Target, and Why This is a Good Buyer Fit. This is a buyer-fit sample to start deep research. We will refine after reviewing your client product website.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Astellas Pharma Inc. | https://www.astellas.com | Head of Translational Research / Regenerative Medicine Program Lead | Large pharma presence typically aligns with regenerative medicine programs and advanced R&D technology adoption. |
| 2 | Takeda Pharmaceutical Company Limited | https://www.takeda.com | Director, R&D Operations / Drug Discovery Technology | Strong fit for pharma R&D and enabling technologies connected to drug discovery and advancement workflows. |
| 3 | Chugai Pharmaceutical Co., Ltd. | https://www.chugai-pharm.co.jp | Senior Manager, Research & Development (Cell/Translational) | Regenerative and translational research stakeholders commonly evaluate enabling reagents, tools, and partnership options. |
| 4 | Shionogi & Co., Ltd. | https://www.shionogi.com | Director, Pharmaceutical R&D / Early Research Technologies Lead | Fit for pharma discovery tools, R&D support systems, and technology partners for advanced research. |
| 5 | Eisai Co., Ltd. | https://www.eisai.com | Head of Digital Transformation (R&D/Operations) / Data & Systems Lead | Pharma Digital Transformation EXPO indicates digital and operational systems are relevant for large R&D organisations. |
| 6 | FUJIFILM Corporation | https://www.fujifilm.com | Business Development Manager (Life Sciences / Cell Research) | Strong positioning around life science materials and systems that can map to regenerative medicine enablement. |
| 7 | Merck (MilliporeSigma) | https://www.merckmillipore.com | Regional Sales Lead (Life Science Tools) / Strategic Partnerships Manager | Regenerative medicine expo includes culture media, reagents, incubators, and cell research related products. |
| 8 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, BD / Strategic Accounts (Cell & Tissue Research) | Fit for incubators, research tooling, and enabling lab products used in cell and tissue engineering workflows. |
| 9 | Sartorius Stedim Biotech | https://www.sartorius.com | Regional Manager, Bioprocessing Sales / C&T (Cell & Tissue) Solutions Lead | Bioprocessing and related enabling platforms often connect with manufacturing readiness and research-to-process needs. |
| 10 | Sekisui Chemical Co., Ltd. | https://www.sekisui.com | Director, Biologics / Regenerative Medicine Solutions | Fit for biomaterials and enabling technologies used by regenerative medicine and research institutions. |
| 11 | Lonza | https://www.lonza.com | Head of Partnerships / BD Manager (Cell Therapy / Biologics Services) | Contract services and licensing are explicitly listed; CDMO/contract partners are natural buyer-fit targets. |
| 12 | Catalent | https://www.catalent.com | Director, Manufacturing Services / Quality & Compliance Partner Lead | Pharma manufacturing and packaging-related buyers align with technology qualification and supply chain partnerships. |
| 13 | Charles River Laboratories | https://www.criver.com | Director, Contract Research (Cell/Translational) / BD Partnerships | Event includes contract services; contract research stakeholders are prime for collaboration conversations. |
| 14 | Wako Pure Chemical Industries, Ltd. | https://www.wako-chem.co.jp | Sales Director, Life Science Reagents / Strategic Account Manager | Reagents and culture-media-related needs map directly to regenerative medicine expo categories. |
| 15 | PeproTech | https://www.peprotech.com | Regional Sales / Product Manager (Cell Culture Reagents) | Culture media and reagents are core expo exhibit categories; supplier-side buyers are highly relevant. |
| 16 | Danaher (various brands) | https://www.danaher.com | Segment Director, Strategic Accounts (Life Sciences Tools) | Digital transformation and lab tooling relevance can align depending on the specific brand’s offering and target lane. |
| 17 | Otsuka Pharmaceutical Co., Ltd. | https://www.otsuka.co.jp | Head of R&D Technology / Regenerative/Translational Lead | Large pharma R&D stakeholders frequently evaluate research enablement and collaboration offerings. |
| 18 | FUJIFILM Cellular Dynamics (FUJIFILM-related life sciences) | https://www.fujifilm.com | Director, Cell Research / iPSC & Cell Platform Partnerships | Strong buyer-fit for cell research ecosystem; regenerative medicine expo includes cell research related products. |
| 19 | Roche (Japan) | https://www.roche.com | Digital Transformation Lead (Pharma R&D/Manufacturing) / Platform Partnerships Manager | Pharma digital transformation and advanced R&D workflows align with the event’s digital transformation lane. |
| 20 | University/Institute Research Centres (Japan-based) | (Target via specific institute page during research) | Professor / PI / Centre Director (Regenerative Medicine) | The official text explicitly notes researchers/doctors from universities visit regenerative medicine expo; institute research leadership is essential for discovery-to-application matching. |
Our next action (to improve accuracy): Share the client product website so we can replace broad samples (like “Danaher” or “University/Institute Research Centres”) with the most precise company/institution targets and the exact best-fit job titles aligned to your product category.
Quick checklist we will use to finalise “best buyers” after your client review
- Does your product map to culture media / reagents / incubators / cell research tools?
- Or does it map to contract services / licensing / partnership enablement?
- Or is it focused on pharma manufacturing & packaging?
- Or is it focused on pharma R&D & drug discovery?
- Or is it focused on digital transformation for pharma operations and quality/data workflows?
Please send: the client website URL and a short product description. We will then return a refined buyer-fit list and the outreach positioning most likely to resonate for INTERPHEX Week Osaka / Regenerative Medicine Expo Osaka.
Data sheet
INTERPHEX WEEK OSAKA – Event Attendee & Buyer Profile Analysis
Event Date: Sep. 30 – Oct. 2, 2026 |
Location: INTEX Osaka, Osaka, Japan |
Event Status: Upcoming |
Research Date: July 1, 2026
Event Overview
| Event Name | INTERPHEX Week Osaka / Regenerative Medicine Expo Osaka |
| Event Date | Sep. 30 – Oct. 2, 2026, 10:00–17:00 JST |
| Event Status | Upcoming |
| Venue | INTEX Osaka |
| City | Osaka |
| State / Region | Osaka Prefecture / Kansai region |
| Country | Japan |
| Organizer | RX Japan GK |
| Official Event Website | interphex.jp/osaka/en-gb.html |
| Event Type | B2B trade exhibition, conference, and industry networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology; Business Services |
| Audience Reach | Primarily national with meaningful Asia-Pacific international participation potential |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium for event details; low for attendance volume because current-year visitor totals were not published in the provided official content |
| Main Purpose of Event | To connect pharmaceutical, biotech, regenerative medicine, manufacturing, packaging, lab, and digital transformation suppliers with industry buyers, researchers, and decision-makers |
About the Event
INTERPHEX Week Osaka is positioned as Western Japan’s largest pharmaceutical and regenerative medicine exhibition, bringing together three specialized shows covering pharma manufacturing and packaging, pharma R&D and drug discovery, and digital transformation for the pharma sector. The event is organized by RX Japan GK and is staged at INTEX Osaka, a major exhibition venue serving the Kansai business corridor.
The show matters because it concentrates a highly targeted buyer audience in one venue: pharmaceutical manufacturers, regenerative medicine companies, cosmetics and medical-related organizations, researchers, laboratory professionals, engineering teams, and technology providers. For suppliers, the event offers strong relevance for sourcing, procurement, partnership development, technical sales, product launches, and lead generation across the pharma innovation value chain.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Procurement and sourcing teams | Pharma manufacturers, biotech firms, CDMOs, laboratory operators | Source equipment, consumables, services, and technology | High-value for vendor selection and supplier qualification |
| R&D and drug discovery teams | Pharma R&D labs, biotech innovators, academic spinouts | Specify research tools, reagents, and lab workflows | Strong for lab instrumentation, assay, and workflow suppliers |
| Manufacturing and operations leaders | Drug manufacturers, packaging plants, fill-finish operators | Own production efficiency, QA, and scale-up decisions | High relevance for automation, packaging, and process technology suppliers |
| Regenerative medicine and cell therapy organizations | Cell therapy firms, tissue engineering groups, advanced therapy companies | Buy culture media, reagents, incubators, and contract services | Highly relevant for specialized life science and cold-chain suppliers |
| Quality, validation, and regulatory teams | Pharmaceutical and medical product manufacturers | Evaluate compliance, qualification, and validation requirements | Important for GMP, data integrity, and compliance-oriented solutions |
| Digital transformation / IT leaders | Pharma IT departments, manufacturing systems teams, digital labs | Own software, data, and automation priorities | Strong fit for MES, LIMS, ERP, analytics, and AI vendors |
| Academic and medical researchers | Universities, hospitals, translational research centers | Influence product evaluation and technique adoption | Relevant for research-grade consumables, instruments, and services |
| Cosmetics and consumer health manufacturers | Beauty, personal care, and functional ingredient companies | Search for innovation, ingredients, processing, and quality tools | Relevant due to overlap with life sciences and formulation technologies |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Osaka | Very high | High | Osaka is identified by the organizer as Japan’s largest pharmaceutical cluster |
| Host region: Kansai / Western Japan | Very high | High | Likely draws pharma and biotech buyers from Kyoto, Hyogo, Nara, Shiga, and nearby industrial corridors |
| Nearby business hubs | High | High | Kyoto, Kobe, Nagoya, and wider Tokai/Kansai life sciences ecosystems |
| National reach: Japan | High | High | Organizer content indicates visitors from across Japan |
| International reach: Asia-Pacific | Moderate | Medium | Official site notes visitors from Japan and Asia for regenerative medicine-related content |
| Cross-border trade corridors | Moderate | Medium | Relevant for suppliers serving Japan, Korea, Taiwan, Singapore, and broader APAC pharma markets |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The event is based in Osaka but is positioned as a major Japan-wide pharma industry gathering |
| Regional | Secondary strength | Kansai and Western Japan attendance is likely strong due to venue proximity and industry clustering |
| Global | Limited but meaningful | International relevance exists through APAC regenerative medicine and pharma supply chain participation, but the event is not primarily global in scale |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | Pharmaceutical manufacturer | Large pharma buyer of manufacturing, digital, and R&D solutions | takeda.com | Procurement Director, Manufacturing Director, IT Director, R&D Operations | Strong Market Fit, Attendance Not Confirmed |
| Astellas Pharma Inc. | Pharmaceutical manufacturer | Pharma R&D and manufacturing stakeholder with broad supplier needs | astellas.com | Strategic Sourcing Manager, QA Director, Lab Operations, Digital Transformation Lead | Strong Market Fit, Attendance Not Confirmed |
| Daiichi Sankyo Company, Limited | Pharmaceutical manufacturer | Likely buyer for manufacturing, analytics, and compliance technologies | daiichisankyo.com | Procurement Manager, Operations Director, Validation Manager, CIO | Strong Market Fit, Attendance Not Confirmed |
| Otsuka Holdings Co., Ltd. | Healthcare/pharma group | Relevant across pharma, nutrition, and health-related innovation procurement | otsuka.com | Category Manager, Procurement Lead, Innovation Manager, Business Development | Strong Market Fit, Attendance Not Confirmed |
| Shionogi & Co., Ltd. | Pharmaceutical manufacturer | Strong fit for pharma equipment, lab, and digital workflow providers | shionogi.com | Director of Procurement, Lab Manager, IT Director, Regulatory Affairs | Strong Market Fit, Attendance Not Confirmed |
| Santen Pharmaceutical Co., Ltd. | Pharmaceutical manufacturer | Eye care pharma company with relevant R&D, manufacturing, and quality functions | santen.com | Procurement Manager, QA Manager, Operations Director, R&D Lead | Strong Market Fit, Attendance Not Confirmed |
| Sumitomo Pharma Co., Ltd. | Pharmaceutical manufacturer | Potential buyer of drug development, digital, and manufacturing solutions | sumitomo-pharma.com | Supply Chain Director, Sourcing Manager, IT Lead, Product Manager | Strong Market Fit, Attendance Not Confirmed |
| Kyowa Kirin Co., Ltd. | Biopharmaceutical company | Biopharma and manufacturing relevance for specialized suppliers | kyowakirin.com | Procurement Director, Manufacturing Engineer, QA/Validation Lead, Digital Lead | Strong Market Fit, Attendance Not Confirmed |
| Nipro Corporation | Medical devices / healthcare manufacturing | Relevant for manufacturing, packaging, and process technology suppliers | nipro.co.jp | Procurement Manager, Plant Manager, Supply Chain Director, Quality Director | Strong Market Fit, Attendance Not Confirmed |
| Sysmex Corporation | Diagnostics / medical technology | Lab and diagnostics stakeholder relevant to research and digital workflows | sysmex.co.jp | R&D Director, Procurement Lead, Product Manager, IT Director | Strong Market Fit, Attendance Not Confirmed |
| FUJIFILM Corporation | Life sciences / imaging / manufacturing technology | Broad relevance to regenerative medicine, materials, and digital transformation | fujifilm.com | Business Development Director, Procurement Manager, Lab Operations, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| Nippon Shinyaku Co., Ltd. | Pharmaceutical manufacturer | Relevant pharma buyer for production and research solutions | nsh.co.jp | Procurement Director, QA Manager, R&D Manager, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| CiRA, Kyoto University | Research institution | Regenerative medicine research user and influencer | cira.kyoto-u.ac.jp | Principal Investigator, Lab Manager, Research Procurement, Program Director | Strong Market Fit, Attendance Not Confirmed |
| National Center for Geriatrics and Gerontology | Medical institution / research | Relevant healthcare buyer for clinical and research solutions | ncgg.go.jp | Director, Procurement Officer, Research Lead, Lab Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Procurement Officer / Head of Procurement | Procurement | C-level / VP | Owns supplier strategy, spend, and vendor approval for pharma operations |
| 2 | Director of Procurement / Strategic Sourcing Manager | Procurement / Sourcing | Director / Manager | Directly evaluates suppliers, RFQs, and commercial terms |
| 3 | Manufacturing Director / Plant Manager | Operations / Manufacturing | Director / Senior Manager | Influences equipment, automation, and process improvement purchases |
| 4 | R&D Director / Lab Manager | Research & Development | Director / Manager | Defines scientific tool and workflow requirements |
| 5 | QA / Validation Manager | Quality / Compliance | Manager / Senior Manager | Critical for compliance, qualification, and regulated systems selection |
| 6 | IT Director / Digital Transformation Lead | IT / Digital | Director / Senior Manager | Key decision-maker for software, data, and automation platforms |
| 7 | Business Development Director / Partnerships Director | Commercial / Partnerships | Director | Relevant for licensing, co-development, and channel discussions |
| 8 | Regulatory Affairs Manager / Compliance Officer | Regulatory / Compliance | Manager / Senior Manager | Evaluates documentation, validation, and product readiness for regulated use |
| 9 | Program Manager / Project Manager | Operations / PMO | Manager | Coordinates implementation, pilots, and cross-functional evaluation |
| 10 | Research Professor / Principal Investigator | Academia / Research | Senior | Influences scientific method adoption, procurement, and collaboration |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core exhibitor and attendee vertical for manufacturing, R&D, and digital transformation | Pharma manufacturers and corporate buyers |
| 2 | Biotechnology | Strong overlap with drug discovery and regenerative medicine | Biotech research and commercialization teams |
| 3 | Medical Devices | Relevant to diagnostics, lab systems, and regulated product environments | Manufacturing and quality decision-makers |
| 4 | Research | Scientific audience for lab and discovery technologies | Lab and research tool buyers |
| 5 | Information Technology & Services | Supports pharma digital transformation, MES, LIMS, and analytics | IT and digital transformation buyers |
| 6 | Electrical/Electronic Manufacturing | Relevant to lab equipment, automation, and instrumentation suppliers | Equipment and automation procurement |
| 7 | Machinery | Strong fit for process, packaging, and production machinery suppliers | Manufacturing modernization buyers |
| 8 | Hospital & Health Care | Relevant for regenerative medicine, clinical translation, and hospital research | Clinical and medical buyers |
| 9 | Chemicals | Relevant for reagents, materials, and formulation inputs | Material and consumables sourcing |
| 10 | Logistics & Supply Chain | Important for temperature-sensitive pharma and cell therapy supply chains | Cold-chain, warehousing, and distribution buyers |
| 11 | Packaging & Containers | Relevant to pharma packaging, labeling, and containment systems | Packaging procurement |
| 12 | Government Administration | Potential public sector healthcare, research, and regulatory stakeholders | Public institutions and procurement teams |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official website text provided by organizer | Use organizer-published visitor totals if updated in a future press release or exhibitor guide |
| Exhibitor count | Forecast only; exact count not confirmed in provided content | Estimated | Organizer disclaimer that exhibitor numbers are forecasts | No current-year numerical count extracted from the official text |
| Buyer count | Not publicly confirmed | Unavailable | No official buyer count published in the provided content | Attendance figure should not be assumed |
| Speaker count | Not publicly confirmed | Unavailable | Conference details referenced, but no count provided in supplied text | Use agenda page if available for event programming review |
| Sponsor count | Not publicly confirmed | Unavailable | No sponsor list included in the provided text | Check exhibitor directory / sponsorship prospectus for updates |
| Historical attendance | Prior-year visitor count referenced on site, but value not shown in provided text | Historical / prior-year evidence | Organizer site references prior event reporting and forecast-based counts | Use only if the numeric figure is later verified on the official visitor count page |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Procurement | Need qualified vendors and competitive pricing | RFQ discussions, supplier qualification meetings, spend optimization | Sourcing, contract manufacturing, consumables, equipment |
| Manufacturing automation | Higher throughput, lower errors, better traceability | Factory-floor demos and efficiency ROI discussions | Robotics, line integration, MES, SCADA, packaging automation |
| Regenerative medicine | Cell culture reliability, contamination control, scale-up support | Scientific product demos and technical discussions | Culture media, reagents, incubators, cell processing, licensing |
| Digital transformation | Need data integration and operational visibility | Workflow mapping, software demos, pilot program discussions | LIMS, ERP, MES, analytics, AI-enabled quality tools |
| Quality and compliance | Validation-ready, audit-friendly systems and documents | Compliance-led selling with evidence packages | GMP systems, validation services, documentation software |
| R&D / drug discovery | Tools that improve speed, accuracy, and reproducibility | Technical consultations with scientists and lab heads | Assays, instrumentation, software, reagents, lab services |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event is tightly aligned to pharma, biotech, regenerative medicine, and lab buyers |
| Decision-maker availability | High | Procurement, operations, R&D, quality, and IT decision-makers are likely attendee groups |
| Data collection potential | High | Strong potential for visitor registration, exhibitor directory, and conference-based prospecting |
| Apollo targeting potential | Very High | Clear vertical and title-based filters exist for pharma, biotech, research, and manufacturing roles |
| Geographic targeting potential | High | Osaka/Kansai and Japan-wide targeting are natural and efficient for outreach |
| Best outreach approach | High-touch B2B email, LinkedIn outreach, exhibitor-targeted account mapping | Focus on technical pain points, compliance, efficiency, and ROI rather than broad brand messaging |
| Overall lead quality | Very High | Specialized industry event with strong commercial intent and decision-maker density |
| Best use case | Lead generation, attendee profiling, exhibitor prospecting, and account-based outreach | Useful for suppliers selling into pharma manufacturing, lab, compliance, and digital transformation teams |
| Limitations / risks | Moderate | Current-year attendee list and attendance totals were not fully public in the provided official content |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Research; Information Technology & Services; Machinery; Electrical/Electronic Manufacturing; Chemicals; Logistics & Supply Chain; Hospital & Health Care | Capture the core buyer ecosystem around pharma manufacturing and life sciences innovation |
| Departments | Procurement; Operations; Research; Information Technology; Quality Assurance; Regulatory Affairs; Engineering; Supply Chain; Business Development | Identify decision-makers and influencers across the buying committee |
| Seniority | Manager; Director; VP; CXO; Owner/Partner where relevant | Prioritize budget holders and strategic evaluators |
| Job titles | Chief Procurement Officer, Procurement Director, Strategic Sourcing Manager, Manufacturing Director, QA Manager, Validation Manager, IT Director, Digital Transformation Lead, R&D Director, Lab Manager, Regulatory Affairs Manager | Precision targeting for event-relevant buyers |
| Geography | Japan; Osaka; Kansai; Tokyo; Kyoto; Hyogo; Aichi; Greater Japan; APAC for international extension | Prioritize nearby and nationally relevant buyer accounts |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Match mid-market suppliers and enterprise pharma buyers |
| Keywords | pharma manufacturing, regenerative medicine, cell therapy, bioprocess, GMP, lab automation, LIMS, MES, packaging, validation, drug discovery, tissue engineering | Sharpen searches to event themes and buying intent |
| Company type | Pharmaceutical manufacturers; biotech firms; research institutions; hospitals; CDMOs; diagnostics companies; medical technology firms | Align to the show’s core visitor and exhibitor ecosystem |
| Technologies | MES, LIMS, ERP, SCADA, automation software, analytics, AI, cold-chain, cleanroom, QA software | Find buyers with active modernization and compliance needs |
| Revenue range | No strict limit; prioritize mid-size to enterprise buyers | Supports both regional procurement teams and multinational pharma accounts |
Suggested Apollo Search Logic: (Pharmaceuticals OR Biotechnology OR Medical Devices OR Research) AND (Procurement OR Sourcing OR Manufacturing OR Quality OR Regulatory OR IT OR R&D) AND (Director OR VP OR Manager OR Head OR Chief) AND (Japan OR Osaka OR Kansai OR Tokyo)
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| INTERPHEX Week Osaka official website | Official organizer source | Event name, dates, venue, organizer, show structure, purpose, and participation messaging | Very High |
| RX Japan GK corporate website | Organizer website | Organizer identity and corporate ownership context | High |
| INTEX Osaka official website | Venue website | Venue identity and location context for Osaka exhibitions | High |
| Official About section on event website | Official event content | Event positioning as a pharma and regenerative medicine exhibition; audience description | Very High |
| Official exhibitor directory page | Official event directory | Potential future confirmation of exhibitors and market mapping | High |
| Official visitor registration page | Official registration page | Visitor access, free registration, and VIP visitor positioning | High |
| Official conference section | Official agenda reference | Conference presence and educational value of the event | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to INTERPHEX WEEK OSAKA — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds